Isabel Hernández

9.2k total citations
23 papers, 461 citations indexed

About

Isabel Hernández is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Isabel Hernández has authored 23 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 9 papers in Psychiatry and Mental health and 7 papers in Molecular Biology. Recurrent topics in Isabel Hernández's work include Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (8 papers) and Genetic Associations and Epidemiology (4 papers). Isabel Hernández is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Dementia and Cognitive Impairment Research (8 papers) and Genetic Associations and Epidemiology (4 papers). Isabel Hernández collaborates with scholars based in Spain, United States and United Kingdom. Isabel Hernández's co-authors include Merçé Boada, Lluís Tárraga, Montserrat Alegret, Agustı́n Ruiz, Sergi Valero, Ana Espinosa, Ana Mauleón, Maitée Rosende‐Roca, James T. Becker and Mar Buendía and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecular Psychiatry.

In The Last Decade

Isabel Hernández

21 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Hernández Spain 12 251 177 130 67 57 23 461
Laura Videla Spain 11 253 1.0× 182 1.0× 111 0.9× 64 1.0× 33 0.6× 30 561
Jung‐Min Pyun South Korea 13 196 0.8× 161 0.9× 95 0.7× 77 1.1× 63 1.1× 44 443
Mary Ann A. DeMichele‐Sweet United States 13 288 1.1× 270 1.5× 113 0.9× 49 0.7× 73 1.3× 15 512
Nicholas J. Ashton United Kingdom 13 336 1.3× 248 1.4× 136 1.0× 89 1.3× 37 0.6× 55 539
Helena Passarelli Giroud Joaquim Brazil 14 191 0.8× 150 0.8× 150 1.2× 66 1.0× 37 0.6× 36 476
Naira Goukasian United States 12 209 0.8× 160 0.9× 79 0.6× 49 0.7× 73 1.3× 23 365
Arousiak Varpetian United States 7 300 1.2× 216 1.2× 89 0.7× 56 0.8× 94 1.6× 8 476
Maria João Leitão Portugal 13 272 1.1× 256 1.4× 105 0.8× 76 1.1× 56 1.0× 22 449
Barbara Schaffer United States 7 298 1.2× 196 1.1× 157 1.2× 66 1.0× 140 2.5× 9 590
Arthur Kay United States 10 192 0.8× 133 0.8× 106 0.8× 54 0.8× 68 1.2× 17 433

Countries citing papers authored by Isabel Hernández

Since Specialization
Citations

This map shows the geographic impact of Isabel Hernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Hernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Hernández more than expected).

Fields of papers citing papers by Isabel Hernández

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Hernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Hernández. The network helps show where Isabel Hernández may publish in the future.

Co-authorship network of co-authors of Isabel Hernández

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Hernández. A scholar is included among the top collaborators of Isabel Hernández based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Hernández. Isabel Hernández is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Shahzad, Wei Yang, Adelina Orellana, et al.. (2024). Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment. Alzheimer s Research & Therapy. 16(1). 171–171. 11 indexed citations
2.
Rojas, Itziar de, Laura del Barrio, Isabel Hernández, et al.. (2023). Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults. International Journal of Molecular Sciences. 24(3). 2186–2186. 2 indexed citations
3.
4.
Alegret, Montserrat, Ana Espinosa, Gemma Ortega, et al.. (2021). From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery. Journal of Alzheimer s Disease. 81(4). 1541–1553. 16 indexed citations
5.
Gomà‐i‐Freixanet, Montserrat, Sergi Valero, Octavio Rodríguez‐Gómez, et al.. (2020). Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort. Behavioural Neurology. 2020. 1–6. 7 indexed citations
6.
Abdelnour, Carla, Sergi Valero, Maitée Rosende‐Roca, et al.. (2020). Gender and sex bias in clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE. Alzheimer s & Dementia. 16(S10). 2 indexed citations
7.
Ahmad, Shahzad, Adelina Orellana, Isabelle Köhler, et al.. (2020). Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease. Alzheimer s Research & Therapy. 12(1). 124–124. 17 indexed citations
8.
Moreno‐Jiménez, Elena P., Itziar de Rojas, César Rodríguez, et al.. (2019). An integration-free iPSC line, ICCSICi007-A, derived from a female Alzheimer's disease patient with the APOE-ε4/ε4 alleles. Stem Cell Research. 41. 101588–101588. 1 indexed citations
9.
DeMichele‐Sweet, Mary Ann A., Elise A. Weamer, Lambertus Klei, et al.. (2019). Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease. Molecular Psychiatry. 25(11). 3109–3111. 3 indexed citations
10.
Pérez‐Grijalba, Virginia, Javier Arbizu, Judith Romero, et al.. (2019). Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study. Alzheimer s Research & Therapy. 11(1). 96–96. 39 indexed citations
11.
Moreno‐Jiménez, Elena P., Itziar de Rojas, César Rodríguez, et al.. (2019). A collection of four integration-free iPSC lines derived from diagnosed sporadic Alzheimer's disease patients with different APOE alleles. Stem Cell Research. 39. 101522–101522. 1 indexed citations
12.
Sánchez‐Juan, Pascual, Sonia Moreno, Itziar de Rojas, et al.. (2019). The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers. Frontiers in Aging Neuroscience. 11. 327–327. 29 indexed citations
13.
DeMichele‐Sweet, Mary Ann A., Elise A. Weamer, Lambertus Klei, et al.. (2017). Genetic risk for schizophrenia and psychosis in Alzheimer disease. Molecular Psychiatry. 23(4). 963–972. 48 indexed citations
14.
15.
Hernández, Isabel, Maitée Rosende‐Roca, Montserrat Alegret, et al.. (2014). Association of TMEM106B rs1990622 Marker and Frontotemporal Dementia: Evidence for a Recessive Effect and Meta-Analysis. Journal of Alzheimer s Disease. 43(1). 325–334. 7 indexed citations
16.
17.
Antúnez, Carmen, Merçé Boada, Concha Moreno‐Rey, et al.. (2011). Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease. Alzheimer s & Dementia. 7(4). e124–9. 17 indexed citations
18.
Ramírez‐Lorca, Reposo, Merçé Boada, Carmen Antúnez, et al.. (2011). The MTHFD1L Gene rs11754661 Marker is Not Associated with Alzheimer's Disease in a Sample of the Spanish Population. Journal of Alzheimer s Disease. 25(1). 47–50. 5 indexed citations
19.
Ramírez‐Lorca, Reposo, Merçé Boada, María Eugenia Sáez, et al.. (2009). GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers. The journal of nutrition health & aging. 13(3). 214–219. 18 indexed citations
20.
Oliveira, Marcelo Fernandes de, et al.. (2007). Avaliação fenotípica de ovelhas da raça texel criadas na Parte Alta do Pantanal.. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Videla Breakdown of academic impact, for papers by Jung‐Min Pyun Breakdown of academic impact, for papers by Mary Ann A. DeMichele‐Sweet Breakdown of academic impact, for papers by Nicholas J. Ashton Breakdown of academic impact, for papers by Helena Passarelli Giroud Joaquim Breakdown of academic impact, for papers by Naira Goukasian Breakdown of academic impact, for papers by Arousiak Varpetian Breakdown of academic impact, for papers by Maria João Leitão Breakdown of academic impact, for papers by Barbara Schaffer Breakdown of academic impact, for papers by Arthur Kay
Rankless by CCL
2026